Eastwood Bio-Medical Canada Inc. (EBM:TSXV) closed at $1.80 on November 6, 2026, down 5.26% on the day. The stock trades 12.6% below its 52-week high of $2.06 and 267.3% above its 52-week low of $0.490. Over the past year, it gained 140.0%. Eastwood Bio-Medical Canada Inc. is part of the Life Sciences sector (Pharmaceuticals).
In 252 trading sessions since November 6, 2025, EBM closed higher on 78 days (31%). Its best day was February 4, 2026 (+50.00%) and its worst was November 11, 2025 (-44.55%). The stock moved 10% or more in a single session 47 times. It opened at least 5% above the previous day's high 20 times.
Eastwood Bio-Medical Canada Inc is engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus. The Company distributes Eleotin products and related products in North America.
Find more stocks like EBM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.